Press Releases Omeros Corporation

Equities

OMER

US6821431029

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
3.4 ^USD	+7.94%		+11.84%	+3.98%

Apr. 01	Tranche Update on Omeros Corporation's Equity Buyback Plan announced on April 1, 2024.	CI
Apr. 01	Omeros Corporation announces an Equity Buyback for $50 million worth of its shares.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Omeros: Q4 Earnings Snapshot	Apr. 01	AQ
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results	Apr. 01	BU
Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024	Mar. 27	BU
Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy	Feb. 20	BU
Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust	Feb. 01	BU
Omeros: Q3 Earnings Snapshot	Nov. 09	AQ
Omeros Corporation Reports Third Quarter 2023 Financial Results	Nov. 09	BU
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023	Nov. 06	BU
Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy	Nov. 03	BU
Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting	Nov. 02	BU
Omeros Corporation Hires Andreas Grauer M.D. as Chief Medical Officer	23-10-19	BU
Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy	23-10-16	BU
Omeros Corporation Reports Second Quarter 2023 Financial Results	23-08-09	BU
Omeros: Q2 Earnings Snapshot	23-08-09	AQ
OMEROS CORPORATION TO ANNOUNCE SECOND QUARTER FINANCIAL RESULTS ON MORNING OF AUGUST 9, 2023	23-08-07	AQ
Omeros Corporation to Announce Second Quarter Financial Results on Morning of August 9, 2023	23-08-04	BU
Omeros Announces Webcast Details for Annual Meeting of Shareholders	23-06-21	BU
Omeros Corporation Announces Availability on Its Website of Materials Accompanying Presentations of OMS906 Data at the 2023 European Hematology Association Congress	23-06-12	BU
Omeros Corporation Announces Late-Breaking Presentation of OMS906 Data at the 2023 European Hematology Association (EHA) Congress	23-06-01	BU
OMEROS CORP : Change in Directors or Principal Officers (form 8-K)	23-05-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Omeros Corporation

Equities

OMER

US6821431029

Press Releases

Filters